Rheumatoid arthritis

• A phase III, randomised, double-blind, multicentre study comparing the efficacy, safety, and immunogenicity of proposed tocilizumab biosimil … Not authorised
  2022-501361-44-00 5 "Adult patients of either gender with active moderate to seve"
• A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active convent … Pending
  2024-516723-14-00 6 "Rheumatoid Arthritis"
• Vaccination against respiratory syncytial virus in patients with inflammatory rheumatic diseases. The impact of anti-rheumatic treatments on … Pending
  2024-518191-31-00 6 "Inflammatory rheumatic disease"
• A study to find how safe different doses of LFD-200 are and how it works in both healthy people and people with moderate to severe rheumato … Pending
  2025-523409-13-00 1 "Moderate to Severe Rheumatoid Arthritis"
• An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants with Rheumatoid Arthritis Pending
  2025-523579-47-00 4 "moderate to severe rheumatoid arthritis (RA)"
• Phase 1b study to assess the safety and tolerability of SR-878 in patients with rheumatoid arthritis Pending
  2025-523678-17-00 3 "rheumatoid arthritis"
• Study QEL-005-CLN-01. Phase I/II study of QEL-005 in patients with diffuse cutaneous systemic sclerosis (dcSSc) and in patients with difficu … Pending
  2025-523971-46-00 7 "Diffuse cutaneous systemic sclerosis (dcSSc) Difficult to tr"
• A study to assess the safety and efficacy of different doses of ELV001 to treat active rheumatoid arthritis in patients with an inadequate r … Pending
  2025-524005-32-00 4
• A First-in-Human, Open-label, Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy o … Pending
  2025-525113-22-00 1 "Rheumatoid Arthritis"
• A study to investigate safety, tolerability, pharmacokinetics, and pharmacodynamics of surovatamig in adult participants with rheumatoid art … Recruiting
  2025-522273-10-00 3 2026-02-24 "Systemic Lupus Erythematosus"
• A study to understand the safety and benefit of AlloNK® with rituximab in patients with hard-to-treat rheumatic diseases Recruiting
  2025-520461-41-00 4 2025-10-22 "Systemic Sclerosis (SSc)"
• A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis Recruiting
  2025-520721-21-00 4 2025-10-20 "Rheumatoid Arthritis"
• A phase Ib, open-label, ascending dose study to assess safety, tolerability and pharmacokinetics of PIT565 in participants with rheumatoid a … Recruiting
  2024-520196-27-00 3 2025-10-01 "Rheumatoid Arthritis"
• A Phase I, Open-Label Study of CLN-978 in Patients with Treatment-Refractory Rheumatoid Arthritis (RA) Recruiting
  2024-519114-31-00 3 2025-05-15 "Treatment-Refractory Rheumatoid Arthritis"
• 3TR-PARTNER-RA Recruiting
  2024-511470-79-00 6 2025-02-11 "Rheumatoid Arthritis"
• A randomized, two-period crossover study to demonstrate the comparability of pharmacokinetics of subcutaneous ianalumab between 2mL auto-inj … Recruiting
  2023-508996-35-00 4 2024-11-18 "Rheumatoid Arthritis"
• Not Applicable Recruiting
  2024-511198-31-00 10 2026-03-24 "Lupus Nephritis"
• An open label, phase I/II study investigating the safety and efficacy of the bispecific T-cell engaging antibody cizutamig (BCMAxCD3) in pat … Recruiting
  2025-522857-20-00 9 2026-01-22 "Severe, treatment refractory primary Sjögren’s disease (pSjD"
• Study of GS-0151 in Participants With Rheumatoid Arthritis Recruiting
  2024-516520-34-00 3 2025-11-17 "Rheumatoid Arthritis"
• A dose-finding Phase I study of F8IL10 intra-articular treatment in Rheumatoid Arthritis Recruiting
  2024-517896-19-00 3 2025-09-29 "Patients with Rheumatoid Arthritis (RA) who, despite treatme"
• A Phase 1 Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants with Severe, Refractory Autoimmune Diseases Recruiting
  2024-517681-41-00 1 2025-08-29 "Systemic Sclerosis"
• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants with Systemic Lupus Ery … Recruiting
  2024-519015-34-00 1 2025-06-30 "Systemic Lupus Erythematosus"
• Reduction of plasma cells as an approach to reset autoimmunity in rheumatoid arthritis Recruiting
  2024-511536-27-00 9 2025-03-11
• COMparison of B-cell dePletion by rituximAb and anti-CD 19 CAR-T therapy in patients with rhEumatoid arthritis- The COMPARE TRIAL Recruiting
  2024-514955-13-00 9 2024-11-29 "Rheumatoid Arthritis"

Showing 1–24 of 55 trials